Ethel Cesarman

Active 1987–2024

101
Papers
27,438
Citations
78
h-index
99
i10-index

Citations

Citations per year for Ethel Cesarman1988: 7 citations1989: 7 citations1990: 11 citations1991: 12 citations1992: 2 citations1993: 7 citations1994: 14 citations1995: 63 citations1996: 201 citations1997: 254 citations1998: 323 citations1999: 388 citations2000: 315 citations2001: 367 citations2002: 288 citations2003: 295 citations2004: 250 citations2005: 203 citations2006: 212 citations2007: 230 citations2008: 168 citations2009: 115 citations2010: 168 citations2011: 155 citations2012: 116 citations2013: 159 citations2014: 170 citations2015: 143 citations2016: 122 citations2017: 122 citations2018: 107 citations2019: 443 citations2020: 386 citations2021: 488 citations2022: 306 citations2023: 211 citations2024: 417 citations2025: 161 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,264 citing papers, 38.8% of this breakdownUnited Kingdom: 410 citing papers, 7% of this breakdownChina: 346 citing papers, 5.9% of this breakdownGermany: 338 citing papers, 5.8% of this breakdownItaly: 305 citing papers, 5.2% of this breakdownFrance: 272 citing papers, 4.7% of this breakdownJapan: 142 citing papers, 2.4% of this breakdownCanada: 140 citing papers, 2.4% of this breakdownSpain: 139 citing papers, 2.4% of this breakdownSwitzerland: 125 citing papers, 2.2% of this breakdownNetherlands: 104 citing papers, 1.8% of this breakdownAustralia: 101 citing papers, 1.7% of this breakdown
0%38.8%Other 19.7%

Fields

  • Medicine69.9%
  • Biochemistry, Genetics and Molecular Biology19.7%
  • Immunology and Microbiology6.3%
  • Engineering1.6%
  • Agricultural and Biological Sciences0.8%
  • Environmental Science0.4%
  • Other1.3%

Topics

  • Viral-associated cancers and disorders17.4%
  • Lymphoma Diagnosis and Treatment9%
  • Cytomegalovirus and herpesvirus research8.4%
  • Herpesvirus Infections and Treatments3.5%
  • Parvovirus B19 Infection Studies3.4%
  • Histiocytic Disorders and Treatments3%
  • Other55.3%

Coauthors

All papers

Open in search
  1. Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma

    Authors: , , , , , , - Science 1994 cited by 5,731

  2. Kaposi sarcoma

    Authors: , , , , , - Nature Reviews Disease Primers 2019 cited by 685

  3. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 265

  4. Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas

    Authors: , , , , - New England Journal of Medicine 1995 cited by 2,876

  5. H1 histones control the epigenetic landscape by local chromatin compaction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 193

  6. Kaposi's sarcoma and its associated herpesvirus

    Authors: , , - Nature reviews. Cancer 2010 cited by 877

  7. The epichaperome is an integrated chaperome network that facilitates tumour survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hediye Erdjument‐Bromage, Pat Zanzonico, Clifford A. Hudis, Lorenz Studer, Gail J. Roboz, Ethel Cesarman, Leandro Cerchietti, Ross L. Levine, Ari Melnick, Steven M. Larson, Jason S. Lewis, Mónica L. Guzmán, Gabriela Chiosis - Nature 2016 cited by 305

  8. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fábio E. Leal, Michael S. Lee, J.P. Saint Martin, Marie-Reine Martin, Sam M. Mbulaiteye, Ronald T. Mitsuyasu, Vivian M. Morris, Charles G. Mullighan, Andrew J. Mungall, Karen Mungall, Innocent Mutyaba, Mostafa Nokta, Constance Namirembe, Ariela Noy, Martin D. Ogwang, Abraham Omoding, Jackson Orem, German Ott, Hilary Petrello, Stefania Pittaluga, James D. Phelan, Juan Carlos Ramos, Lee Ratner, Steven J. Reynolds, P Rubinstein, Gerhard Sissolak, Graham W. Slack, Shaghayegh Soudi, Steven H. Swerdlow, Alexandra Traverse‐Glehen, Wyndham H. Wilson, Jasper Wong, Robert Yarchoan, Jean C. Zenklusen, Marco A. Marra, Louis M. Staudt, David W. Scott, Ryan D. Morin - Blood 2022 cited by 86

  9. KSHV/HHV8-mediated hematologic diseases

    Authors: , , - Blood 2021 cited by 115

  10. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells

    Authors: , , , , , , , , , , , , , , , , - Blood 2014 cited by 337

  11. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2017 cited by 134

  12. A portable device for nucleic acid quantification powered by sunlight, a flame or electricity

    Authors: , , , , , , , , - Nature Biomedical Engineering 2018 cited by 90

  13. Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mikhail Roshal, Lisa Giulino‐Roth - Blood Cancer Discovery 2023 cited by 62

  14. DNA methylation enzymes and PRC1 restrict B-cell Epstein–Barr virus oncoprotein expression

    Authors: , , , , , , , , , , - Nature Microbiology 2020 cited by 65

  15. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus

    Authors: , , , , , , - Blood 1996 cited by 1,185

  16. Gammaherpesviruses and Lymphoproliferative Disorders

    Authors: - Annual Review of Pathology Mechanisms of Disease 2013 cited by 196

  17. Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice

    Authors: , , , , - Journal of Clinical Investigation 2011 cited by 113

  18. Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma

    Authors: , , , , , , , , , , , , , , , - Molecular Cancer Therapeutics 2017 cited by 95

  19. Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , - Blood 2020 cited by 58

  20. Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2023 cited by 31

  21. HIV-associated lymphomas and gamma-herpesviruses

    Authors: , , , , - Blood 2008 cited by 354

  22. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

    Authors: , , , , , , , , , , , , , , , , , - Blood 2020 cited by 70

  23. Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study

    Authors: , , , , , , , , , , , , , , , , , , - Cancer 2023 cited by 17

  24. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

    Authors: , , , , , , , , , , , , , - Blood 2006 cited by 230